This Is MS Multiple Sclerosis Knowledge & Support Community

Posted: **Thu May 19, 2011 10:46 pm**

Biogen Idec Inc. reported 13 more cases of a rare brain infection occurring in multiple-sclerosis patients taking the drug Tysabri, sold with Elan Corp, bringing the affected patients to 124 as of May 4.

The Weston, Mass., biotech company said there was one more death among those patients, bringing total deaths to 23.

The incidence of the infection--progressive multifocal leukoencephalopathy, or PML--is updated monthly and is closely watched.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1905

Posted: **Thu Jun 16, 2011 9:18 am**

These numbers can now be updated to 133 cases of PML. Don't know if there were any deaths included in the recent 9 additional patients.

Harry

This Is MS Multiple Sclerosis Knowledge & Support Community

1 death and 13 more cases of PML in Tysabri MS patients

1 death and 13 more cases of PML in Tysabri MS patients

Re: 1 death and 13 more cases of PML in Tysabri MS patients